• Latest Posts

Shire’s Hemophilia Gene Therapy Boosted by Orphan Drug Designation

British Researchers Develop Clever Nanoparticles to Kill Cancer Cells

The UK Recommends the use of GSK’s €594,000 Gene Therapy

Update: GSK’s Shingles Vaccines Impresses FDA Panel who Push for its Approval

British Scientists Prove that it Takes Very Few Mutations to Cause Cancer

French Biotech‘s Bacterial Product is Ready to Enter the Anti-Aging Skincare Market


FDA Grants Belgian Crohn’s Disease Candidate Orphan Designation

Transgene‘s Hepatitis B Vaccine Does the Business at Phase I

Swiss Biotech Rakes in $200M to Accelerate Antibody-based Cancer Treatments

Peanut Allergy Trial Fails but French Biotech Keeps Pushing for Approval

A Peptide Reduces Bleeding in Surgery in Phase II Trials

Leading Pharma-Academic Partnership Unravels the Mystery of a Major Cancer Gene